Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
MRD registry and multicenter, randomized controlled pragmatic trial of standard intensity versus reduced intensity consolidation treatment in MRD-negative patients with AML or CLL (RESOLVE trial).
Sponsor Medizinische Hochschule Hannover
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase Ia/IIb study of PHD inhibitor molidustat in combination with IDH1 inhibitor ivosidenib in IDH1-mutated relapsed/refractory AML or MDS/AML patients
Sponsor Medizinische Hochschule Hannover
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open labelled phase III adjuvant trial of disease-free survival in patients with resected pancreatic ductal adenocarcinoma randomized to allocation of oxaliplatin- or gemcitabine-based chemotherapy by standard clinical criteria or by a transcriptomic treatment specific stratification signature (ESPAC-6)
Sponsor Universitaetsklinikum Heidelberg AöR
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2
Sponsor Universitaetsklinikum Ulm AöR
- Start (EU)
- Latest update
- Estimated end
A phase II, open-label, randomized, multi-center study comparing the efficacy and safety of Sacituzumab govitecan versus investigator’s choice in patients with cancer of unknown primary (CUP) who are relapsed after or refractory to platinum-based chemotherapy
Sponsor Universitaetsklinikum Heidelberg AöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR
Sponsor University Of Cologne
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumours
Sponsor Vall D Hebron Institute Of Oncology
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts?
The 2026-10-09 snapshot links Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts to 7 distinct CTIS trials. Recorded services include Statistical analysis, Bioinformatic analysis (“NB-profiler software”), Clinical monitoring, Data management, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology, Gastroenterology. Recorded phases include Phase 2, Phase 3, Phase 1. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts conducted?
The linked trials record locations in 13 countries, including Germany, France, Italy, Netherlands, Sweden. These are trial locations, not confirmed office locations or countries where Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts delivered services.
What can this page tell me about Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts